Home LiteratureArticle Details
PMID: 4381474 Published · ppublish English Journal Article

Turnover of rat liver tyrosine transaminase: stabilization after inhibition of protein synthesis.

Science (New York, N.Y.) ·Vol. 156 ·No. 3774 ·1967-04-28 ·Pages 525-8

Kenney FT

Abstract

Turnover of the rat liver tyrosine transaminase in vivo was measured by a label and chase procedure under conditions where the amount of enzyme undergoes no change. Half-life of the (14)C-labeled enzyme in this basal condition was found to be 1.5 +/- 0.3 hours. Inhibitors of protein synthesis (cycloheximide or puromycin) do not appreciably influence the basal enzyme level over a 5-hour period, although these drugs will block hormonal induction of this enzyme. In pulse-labeling experiments, cycloheximide blocked transaminase synthesis almost completely. The conclusion that enzyme degradation, as well as synthesis, must be blocked when protein synthesis is stopped was confirmed in experiments showing that labeled enzyme is stable in the liver of rats treated with cycloheximide The participation of a continuously synthesized polypeptide in the degradative phase of transaminase turnover is suggested.

MeSH Terms
Animals Antifungal Agents/pharmacology Carbon Isotopes Cycloheximide/pharmacology Leucine/metabolism Liver/enzymology Peptides/metabolism Rats Transaminases/metabolism Tyrosine Transaminase/metabolism
Chemicals
Antifungal Agents Carbon Isotopes Peptides Cycloheximide Transaminases Tyrosine Transaminase Leucine
Authors & Affiliations
1 authors, click to expand affiliations / ORCID
Kenney F T
Article Info
Journal
Science (New York, N.Y.)
Abbr.
Science
ISSN
0036-8075
Published
1967-04-28
Pages
525-8
Language
English
Region
United States
NLM ID
0404511
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com